Spero closes $30M series B round

By BC Staff | Feb 3, 2016 | 3:08 AM GMT

Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) secured $30 million in a tranched series

Read the full 140 word article

User Sign In